Vetsys Pharmaceutical
The global nutraceutical liquids market is undergoing a seismic shift. As consumers and veterinary professionals move away from traditional pill and tablet formats, the demand for high-bioavailability liquid solutions has skyrocketed. Liquid supplements and medicines offer 98% absorption rates compared to the 10-20% typical of solid forms, making them the preferred choice for intensive animal farming and modern human wellness.
Valued at over USD 35 Billion in 2023, the liquid nutraceutical segment is projected to grow at a CAGR of 7.2% through 2030, driven by the "Preventative Health" trend.
Large-scale poultry and livestock operations now rely on water-soluble vitamin complexes and liquid infusions for rapid herd-wide treatment and nutrition.
Nano-emulsification and liposomal delivery systems are now being integrated into liquid OEM manufacturing to enhance the stability of volatile vitamins like A, D, and E.
In this competitive landscape, the difference between a market leader and a follower lies in formulation stability. Zhengzhou Vetsys Pharmaceutical Co., Ltd. leverages its 18+ years of expertise to solve the industry's hardest challenges: preventing oxidation in liquid vitamins and ensuring consistent potency throughout the product shelf life.
Established in 2005, Zhengzhou Vetsys Pharmaceutical Co., Ltd. (Vetsys) has evolved from a local pharmaceutical workshop into a global titan of animal health. With a registered capital of 30 million RMB and a multi-disciplinary facility, we bridge the gap between scientific research and industrial-scale manufacturing.
Our facility operates under strict Good Manufacturing Practices (GMP), ensuring that every drop of oral solution and every gram of powder meets international safety standards. By 2015, Vetsys had already achieved annual domestic sales exceeding USD 20 million, cementing our status as one of China's top animal pharmaceutical producers.
Global enterprises are increasingly turning to Chinese partners like Vetsys for their OEM/ODM needs. Why? It's not just about cost; it's about the integrated supply chain efficiency and R&D speed that only a vertically integrated manufacturer can provide.
Our independent research institute allows us to move from a client's concept to a stabilized liquid prototype in as little as 3 weeks, significantly faster than Western counterparts.
By leveraging China's vast raw material market for pharmaceutical ingredients, we provide high-purity extracts at a fraction of the global average cost without compromising E-E-A-T standards.
Unique to Vetsys is our in-house packaging capability. We don't just make the liquid; we make the bottles through blow molding and injection molding, ensuring perfect seal integrity.








Our nutraceutical liquids are formulated for diverse applications, ranging from intensive agricultural environments to high-end pet wellness retail brands.
In regions with high humidity or extreme temperatures, powdered vitamins often clump and lose efficacy. Our Multivitamin Oral Solution Vitamin Adeck is designed for water-line administration, ensuring that even sick animals with reduced appetite receive critical micronutrients through their water intake.
Liquid infusions, such as our Oxytetracycline Raw Material and Cefquinome Sulfate Intrauterine Infusion, are critical for managing postpartum inflammatory issues in dairy cattle, significantly reducing the recovery window and protecting milk yield.
The "humanization" of pets has led to a surge in demand for liquid drops like Vitamin B Complex Liquid Drops. These allow owners to precisely dose supplements based on breed weight, offering a "clean label" alternative to flavored chewables that often contain fillers.
At Vetsys, we are driven by our mission to improve animal health through continuous innovation, world-class quality, and sustainable practices. We are committed to creating value for our customers, employees, and society as we continue to shape the future of animal healthcare through science-backed liquid solutions.